Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases.
Rabinowitz KM, Navon M, Edelman-Klapper H, Zittan E, Bar-Gil Shitrit A, Goren I, Avni-Biron I, Ollech JE, Lichtenstein L, Banai-Eran H, Yanai H, Snir Y, Pauker MH, Friedenberg A, Levy-Barda A, Segal A, Broitman Y, Maoz E, Ovadia B, Aharoni Golan M, Shachar E, Ben-Horin S, Maharshak N, Mor M, Ben Zvi H, Eliakim R, Barkan R, Sharar-Fischler T, Goren S, Krugliak N, Pichinuk E, Mor M, Werbner M, Alter J, Abu-Taha H, Kaboub K, Dessau M, Gal-Tanamy M, Cohen D, Freund NT, Dotan I, On Behalf Of The Responses To Covid-Vaccine Israeli Ibd. Rabinowitz KM, et al. Among authors: sharar fischler t. Vaccines (Basel). 2022 Jul 26;10(8):1186. doi: 10.3390/vaccines10081186. Vaccines (Basel). 2022. PMID: 35893835 Free PMC article.
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel.
Avni-Biron I, Bar-Gil Shitrit A, Koslowsky B, Levartovsky A, Kopylov U, Weisshof R, Aviv Cohen N, Maharshak N, Hovel D, Israeli E, Naftali T, Goren I, Snir Y, Ollech JE, Banai-Eran H, Broitman Y, Sharar-Fischler T, Dotan I, Yanai H. Avni-Biron I, et al. Among authors: sharar fischler t. Dig Liver Dis. 2022 Feb;54(2):192-197. doi: 10.1016/j.dld.2021.11.009. Epub 2021 Dec 7. Dig Liver Dis. 2022. PMID: 34887214
Increasing adherence to the Mediterranean diet and lifestyle is associated with reduced fecal calprotectin and intra-individual changes in microbial composition of healthy subjects.
Godny L, Reshef L, Sharar Fischler T, Elial-Fatal S, Pfeffer-Gik T, Raykhel B, Rabinowitz K, Levi-Barda A, Perets TT, Barkan R, Goren I, Ollech JE, Yanai H, Gophna U, Dotan I. Godny L, et al. Among authors: sharar fischler t. Gut Microbes. 2022 Jan-Dec;14(1):2120749. doi: 10.1080/19490976.2022.2120749. Gut Microbes. 2022. PMID: 36226673 Free PMC article.
Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts.
Goren I, Sharar Fischler T, Yanai H, Pal P, Adigopula B, Pendyala S, Ganesh G, Vishnubhotla R, Rabinowitz KM, Shaham Barda E, Yadamreddy D, Godny L, Peleg N, Banerjee R, Dotan I; Indo-Israeli IBD GastroEnterology Partnership (TIIIGER). Goren I, et al. Among authors: sharar fischler t. J Clin Med. 2022 Nov 22;11(23):6899. doi: 10.3390/jcm11236899. J Clin Med. 2022. PMID: 36498474 Free PMC article.
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort Study.
Albshesh A, Bannon L, Sharar Fischler T, Truyens M, Vavricka SR, Tepes K, Pugliese D, Savarino EV, Zittan E, Drobne D, Roblin X, Bar-Gil Shitrit A, Armuzzi A, Lobaton T, Maharshak N, Yanai H, Ben-Horin S, Kopylov U. Albshesh A, et al. Among authors: sharar fischler t. J Clin Med. 2023 Mar 26;12(7):2503. doi: 10.3390/jcm12072503. J Clin Med. 2023. PMID: 37048587 Free PMC article.
A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn's Disease Treated by a Multidisciplinary Team: 1-Year Outcomes.
Yanai H, Sharar Fischler T, Goren I, Eran-Banai H, Ollech JE, Snir Y, Broitman Y, Barkan R, Pfeffer-Gik T, Godny L, Kutokov Y, Friedeberg A, Pauker MH, Rabinowitz KM, Avni-Biron I, Dotan I. Yanai H, et al. Among authors: sharar fischler t. Crohns Colitis 360. 2023 Oct 18;5(4):otad064. doi: 10.1093/crocol/otad064. eCollection 2023 Oct. Crohns Colitis 360. 2023. PMID: 37941598 Free PMC article.
Dynamic response diversity of NFAT isoforms in individual living cells.
Yissachar N, Sharar Fischler T, Cohen AA, Reich-Zeliger S, Russ D, Shifrut E, Porat Z, Friedman N. Yissachar N, et al. Among authors: sharar fischler t. Mol Cell. 2013 Jan 24;49(2):322-30. doi: 10.1016/j.molcel.2012.11.003. Epub 2012 Dec 6. Mol Cell. 2013. PMID: 23219532 Free article.
Discordant effects of Janus kinases inhibition ex-vivo on inflammatory responses in colonic compared to ileal mucosa.
Kaboub K, Abu-Taha H, Arrouasse J, Shaham-Barda E, Wasserberg N, Hayman-Manzur L, Friedenberg A, Levy-Barda A, Goren I, Levi Z, Banai-Eran H, Avni-Biron I, Ollech JE, Sharar-Fischler T, Yanai H, Cohen-Kedar S, Dotan I, Rabinowitz KM. Kaboub K, et al. Among authors: sharar fischler t. J Crohns Colitis. 2024 Jul 29:jjae117. doi: 10.1093/ecco-jcc/jjae117. Online ahead of print. J Crohns Colitis. 2024. PMID: 39073573
Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study.
Ollech JE, Eran-Banai H, Goren I, Sharar Fischler T, Avni-Biron I, Snir Y, Broitman Y, Cohen S, Friedenberg A, Pauker MH, Dotan I, Yanai H. Ollech JE, et al. Among authors: sharar fischler t. Ann Med. 2024 Dec;56(1):2358183. doi: 10.1080/07853890.2024.2358183. Epub 2024 May 30. Ann Med. 2024. PMID: 38813808 Free PMC article. Clinical Trial.